NR1H3 and cancer: However, a pharmacological activation of LXRα alone does not lead to lipotoxicity and cell death in cancer cells, since saturated C16/C18 fatty acids are rapidly desaturated by SCD1 (another downstream target of LXRα [10]) to nontoxic mono-unsaturated fatty acids (Fig. 1a).